Diabetes Health TV introduces Neuragen
Filed under: Type 1, Type 2, Childhood, Adult Onset, Events, Products, Magazines, Allie Beatty, Complications, Personalities
Creator of Diabetes Health Magazine, Scott King, has been a type 1 diabetic for over 34 years. Needless to say, he knows diabetes, and he is doing a remarkable job of introducing cutting-edge treatments for diabetics. In the first Diabetes Health TV broadcast, he shared interviews from the recent AADE Conference. A really exciting product he featured is called Neuragen - a topical treatment for diabetes neuropathy.
With diabetes neuropathy, people experience pain due to damage to the peripheral nerves. Neuropathic pain is often characterized by burning sensations or shooting pain, or may occur as numbness or chronic itching. Clinical trials have shown Neuragen to be effective in 70% of patients for the pain associated with diabetes. The ingredients are pretty kosher, too. Neuragen is made of a proprietary blend of essential oils from special species of geranium, lavender, bergamot, eucalyptus, and tea tree.
The Neuragen rep was blunt when he described the effective nature of this all natural product - using more does not make it any more effective! You have to admire his refreshing honesty. But like I said upfront - if Scott King is willing to spend the time getting the scoop on this product - it's probably worth your time using it. For more interviews, checkot the full coverage of the AADE Conference on Diabetes Health TV!
Dr. Bernstein answers your questions on September 19th
Filed under: Type 1, Type 2, Childhood, Adult Onset, Drugs, Events, Opinion, Allie Beatty, Support, Care, Complications, Personalities
Dr. Bernstein, a world leading authority in diabetes, is hosting a live internet broadcasts to answer your questions on diabetes. Diabetes 911 is setup to stop the complications of diabetes before it's an emergency. Here's a link to the page where you can submit your questions, to be answered on his next broadcast -- September 19, 2007.
Just a heads-up for The Diabetes Blog reading community - AOL has announced they will be retiring The Diabetes Blog on September 14, 2007. So this is a preemptive blog to get your calendar out, send yourself a reminder email titled: OPEN ON SEPTEMBER 19th!!!!
This will not be my last blog shared with you, all mighty readers of the blogosphere. I'm working to get my proverbial welcome mat in place to continue unfolding the mysteries of diabetes on LoveDiabetes.com. More to come...
Pennsylvania announces diabetes action plan partially funded by CDC
Filed under: Type 1, Type 2, Childhood, Adult Onset
Governer Ed Rendell is worried. An estimated eight percent of Pennsylvanians have diabetes. Nearly 800,000 people. We all know money talks, and what has caught the attention of state politicians is the tremendous cost to manage chronic diseases.
Governor Rendell recently shared that about 78 percent of the state's health care costs are linked to 20 percent of chronic diseased patients. The Governor has announced The Pennsylvania Diabetes Action Plan to improve how Pennsylvanians with chronic disease benefit from future health care.
In an effort to prepare Pennsylvania to educate the public about diabetes and diabetes prevention, and improve management of the disease to reduce complications, the Plan focuses on four key areas: surveillance, standards of care, health policy, and evaluation.
Truly a collaborative of care, more than 200 stakeholders, agencies, organizations and individuals contributed to the Pennsylvania Diabetes Action Plan. The plan was funded by the Centers for Disease Control and Prevention (CDC) and a state appropriation.
In 2005, potentially avoidable hospitalizations for diabetics in Pennsylvania cost nearly $730 million. Now that is a number even the Governor cannot ignore.
Mapping Diabetes
Filed under: Type 2, Adult Onset, Diet, Lifestyle, Research, Daily News
Scientists have mapped the genes responsible for causing type 2 diabetes. This new research is giving hope to new tests that can predict an individuals risk for developing the disease and future treatments.
The study compared the genetic make-up of 700 people with type 2 diabetes and a family history of the condition, with 700 diabetes-free people. Four points on the gene map linked to a person's diabetes risk and were confirmed with another group of 5,000 type 2 diabetics. The findings of this research could explain up to 70% of the genetics related to developing diabetes. A particular zinc transporter, known as SLC30A8, which regulates insulin secretion, was shown to have a mutation. Researchers feel they may be able to treat some cases of diabetes by correcting this mutation.
These findings will allow for the creation of a genetic test to predict people's risk of developing type 2 diabetes, as well as better treatments for the presiding cause of their diabetes. Nary a day passes that I am not motivated for the future of all diabetics. This is the type of research that strengthens my faith in the coming of a cure. Identify the nature of the problem and nip it in the bud.
Too good to be true? NIH explores insulin regimen for diabetes prevention
Filed under: Type 1, Drugs, Research
It sounds just too good to be true: preventing or delaying the onset of Type 1 diabetes through a simple daily insulin regimen. Yet a number of health experts believe that giving insulin daily to those at risk of developing Type 1 diabetes, or those newly-diagnosed with the disease, could do just that. You see, it seems there's evidence that taking an oral dose of insulin on a regular basis brings about an increased tolerance for the substance or a "quieting of the immune system." And that could prevent diabetes or at least delay it for a few years.The National Institutes of Health (NIH) wants to find out what's what. It was announced yesterday that the NIH will fund a world-wide network of research into the issue. The research program will go by the name of Type 1 Diabetes TrialNet and will involve the participation of more than one hundred medical centers both here in the US and in Canada, Australia, and in parts of Europe. Individuals at risk for Type 1 diabetes - who can be identified through a simple blood test which identifies the presence of a certain type of autoantibodies - are currently being enrolled for the study. (I have no idea if they're looking for volunteers in the US, by the way - sorry.)
Talk about your big science breakthrough, huh? I mean, if insulin really can be used as a preventative...well, that would be fabulous in and of itself. But you would also have the added bonus that it could be achieved simply, with no side-effects (because insulin is quickly broken down by the digestive system), and it would be affordable. That last one's important. How refreshing it would be to have a big medical breakthrough associated with humble old insulin instead of some ultra-expensive wonder drug!
Diabetes hits hard in New York City
Filed under: Type 2, Research, Daily News, Support
It's a pretty well-known fact that type 2 diabetes is hitting New York City hard. And the powers-that-be in the City are doing something about it: New York City was the first place in the nation to initiate a diabetes-tracking registry intended to guide healthcare spending to maximum effect.So, just how bad is the situation? The city's health department just completed a major study on that very topic and made the results public this week. Some numbers: diabetes causes 20,000 hospitalizations, 3,000 amputations, 1,400 cases of kidney failure, and 4,700 diabetes-related deaths annually. The financial cost of treatment is a staggering $6.5 billion annually.
The report clearly shows that people in lower socioeconomic groups, clustered in a handful of poorer neighborhoods, are suffering disproportionately to the well-heeled and well-educated residents of the chic Upper East Side.
As is the case everywhere in the US - not to mention, globally - a great many people with type 2 diabetes or who are at risk for the disease do not know it, and city officials are aiming to exponentially increase awareness in coming years. The entire report is accessible online in PDF-form at the NYC Department of Health and Mental Hygiene's website.
Does Diabetes Boost Parkinson's Risk?
Filed under: Type 2, Adult Onset, Lifestyle, Research
Acording to a Finnish study, diabetes may increase the risk of developing Parkinson's disease.
Researchers have found that people with type 2 diabetes were more than 80% more likely to be later diagnosed with Parkinson's disease than people without diabetes. This is the first study to suggest that diabetes may be a risk factor of Parkinson's disease, a progressive disease that causes muscle rigidity and tremors.
The study followed a group of more than 50,000 men and women over a period of 18 years. During that time, 324 men and 309 women developed Parkinson's disease. People who had type 2 diabetes at the start of the study were far more likely to be later diagnosed with Parkinson's disease. Overall, after adjusting for other possible risk factors for Parkinson's disease, men and women with type 2 diabetes were 83% more likely to develop Parkinson's disease than those without it.
Although the exact nature of the relationship between diabetes and Parkinson's disease is unclear, researchers say several lifestyle factors may be associated with both disorders. Among these factors are: obesity, cigarette smoking, and lack of physical activity.
Perhaps further research between the association of diabetes and Parkinson's disease could help researchers better understand an avenue to a cure. . Pioglitazone is a drug used to treat diabetes. It may also help fight the onset of Parkinson's. Thanks to funding from The Michael J. Fox Foundation we may be closer to clinical trials and an answer.
UK diabetes care basic, at best
Filed under: Type 1, Type 2, Daily News, Support, Care
British watchdog group The Healthcare Commission just gave diabetes care in the UK a lukewarm review. Its study of the facilities in which British diabetics receive care concludes that care levels overall are basic, at best. Most of the places (73%) surveyed in the study were rated "fair," meaning patients know what medications they are supposed to be on and when they should be taking them. They also know they should be getting annual checkups. Only five percent of facilities were rated "excellent by the Commission.The system is lacking, however, when it comes to anything beyond those most basic of services. Just like here in the US, most British people with diabetes are not receiving help with diabetes management. Studies suggest that regular consultations with a health "coach" on an individual basis could really improve patient outcomes. One reason they are helpful is because they get patients to come up with a care plan tailored for each person, making it more likely he/she will be able to stick with it.
Diabetes UK head of healthcare policy, Bridget Turner, agrees with the Commission's conclusions: "The NHS [National Health Service] has to focus more on...self-care. For people with diabetes, 95% of diabetes management is self-care."
To read more, click here or visit the Healthcare Commission's own web summary of the report.
Rats it's a Virus
Filed under: Type 1, Childhood, Lifestyle, Drugs, Research
No kidding! The rats are leading researchers to triggering events causing diabetes. The new findings suggest that there is, indeed, a genetic susceptibility to diabetes, but that the precipitating event is a viral infection.
The virus in question is the Ljungan virus. Previous reports indicate that infections with the Ljungan virus can induce diabetes in laboratory rats, and that the diabetes can be reversed if the animals are treated with antiviral drugs before the destruction of insulin-secreting islet cells becomes widespread.
I'm not sure how everybody else out there got their D-card. My diagnosing event happened shortly after I had the chicken pox, back in '85. The childhood christening event apparently left me out in the cold and caused the love-hate relationship between my islets and my insulin autoantibodies. Lucky me. Thanks to all the readers out there who have already shared their sequence of diagnosis with me. What's your story? Please, share with us.
[RESEARCH] Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis
Objective To quantify the effectiveness of pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance.
Data sources Medline, Embase, and the Cochrane library searched up to July 2006. Expert opinions sought and reference lists of identified studies and any relevant published reviews checked.
Study selection Randomised controlled trials that evaluated interventions to delay or prevent type 2 diabetes in individuals with impaired glucose tolerance.
Results 21 trials met the inclusion criteria, of which 17, with 8084 participants with impaired glucose tolerance, reported results in enough detail for inclusion in the meta-analyses. From the meta-analyses the pooled hazard ratios were 0.51 (95% confidence interval 0.44 to 0.60) for lifestyle interventions v standard advice, 0.70 (0.62 to 0.79) for oral diabetes drugs v control, 0.44 (0.28 to 0.69) for orlistat v control, and 0.32 (0.03 to 3.07) for the herbal remedy jiangtang bushen recipe v standard diabetes advice. These correspond to numbers needed to treat for benefit (NNTB) and harm (NNTH) of 6.4 for lifestyle (95% credible interval, NNTB 5.0 to NNTB 8.4), 10.8 for oral diabetes drugs (NNTB 8.1 to NNTB 15.0), 5.4 for orlistat (NNTB 4.1 to NNTB 7.6), and 4.0 for jiangtang bushen (NNTH 16.9 to NNTB 24.8).
Conclusions Lifestyle and pharmacological interventions reduce the rate of progression to type 2 diabetes in people with impaired glucose tolerance. Lifestyle interventions seem to be at least as effective as drug treatment.